VIM and lung cancer: Therefore, to further evaluate whether miR-200c can inhibit EMT processes in lung cancer, we examined the expression of α-SMA, vimentin, and β-catenin expression by real-time PCR (Fig 6A), western blotting (Fig 6B), and immunocytochemical staining (Fig 6C).